The best route
[Miranda-Filho DB] and colleagues,2 in a randomised controlled trial of 120 patients with tetanus, allocated 58 patients to antitetanus globulin by the intrathecal and intramuscular route (treatment group), and 62 to antitetanus globulin by the intramuscular route (controls). Patients in the treatme...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2004-10, Vol.364 (9444), p.1487-1488 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1488 |
|---|---|
| container_issue | 9444 |
| container_start_page | 1487 |
| container_title | The Lancet (British edition) |
| container_volume | 364 |
| creator | Kashyap, Ajit Singh Anand, Kuldip Parkash Kashyap, Surekha Anand, Abhijeet |
| description | [Miranda-Filho DB] and colleagues,2 in a randomised controlled trial of 120 patients with tetanus, allocated 58 patients to antitetanus globulin by the intrathecal and intramuscular route (treatment group), and 62 to antitetanus globulin by the intramuscular route (controls). Patients in the treatment group had greater clinical benefits than controls. Those treated by the intrathecal route had a better disease progression than those treated intramuscularly. |
| doi_str_mv | 10.1016/S0140-6736(04)17268-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67005279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673604172681</els_id><sourcerecordid>726805981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-f18bc61de84cde7d81996e0695ded455f05a588b58ce07e8e562182002b5a7ff3</originalsourceid><addsrcrecordid>eNqFkEtLAzEUhYMotlb9B0pREF2M3kxzk8xKpPiCggsruAszyR2c0nZqMiP4700fKAji6m6-e87hY-yIwyUHLq-egQtIpBrIcxAXXKVSJ3yLdblQIkGhXrdZ9xvpsL0QJgAgJOAu63BEAK11lx2O36hfUGj6vm4b2mc7ZT4NdLC5PfZydzsePiSjp_vH4c0osQMpmqTkurCSO9LCOlJO8yyTBDJDR04gloA5al2gtgSKNKFMuU4B0gJzVZaDHjtb5y58_d7GejOrgqXpNJ9T3QYjFQCmKovg6S9wUrd-HreZNPZliJjySJ38RcVlwCFSEcI1ZH0dgqfSLHw1y_2n4WCWTs3KqVkKMyDMyqlZhh9vwttiRu7nayMxAtdrgKKxj4q8CbaiuSVXebKNcXX1T8UXgqOBxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199010552</pqid></control><display><type>article</type><title>The best route</title><source>MEDLINE</source><source>EBSCOhost Business Source Complete</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Kashyap, Ajit Singh ; Anand, Kuldip Parkash ; Kashyap, Surekha ; Anand, Abhijeet</creator><creatorcontrib>Kashyap, Ajit Singh ; Anand, Kuldip Parkash ; Kashyap, Surekha ; Anand, Abhijeet</creatorcontrib><description>[Miranda-Filho DB] and colleagues,2 in a randomised controlled trial of 120 patients with tetanus, allocated 58 patients to antitetanus globulin by the intrathecal and intramuscular route (treatment group), and 62 to antitetanus globulin by the intramuscular route (controls). Patients in the treatment group had greater clinical benefits than controls. Those treated by the intrathecal route had a better disease progression than those treated intramuscularly.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(04)17268-1</identifier><identifier>PMID: 15500888</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Female ; Humans ; Immunoglobulins ; Infusions, Intravenous ; Injections, Intramuscular ; Injections, Spinal ; Tetanus ; Tetanus - therapy ; Tetanus Antitoxin - administration & dosage</subject><ispartof>The Lancet (British edition), 2004-10, Vol.364 (9444), p.1487-1488</ispartof><rights>2004 Elsevier Ltd</rights><rights>Copyright Lancet Ltd. Oct 23-Oct 29, 2004</rights><rights>Copyright Elsevier Limited Oct 23, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c364t-f18bc61de84cde7d81996e0695ded455f05a588b58ce07e8e562182002b5a7ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2069955521?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15500888$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kashyap, Ajit Singh</creatorcontrib><creatorcontrib>Anand, Kuldip Parkash</creatorcontrib><creatorcontrib>Kashyap, Surekha</creatorcontrib><creatorcontrib>Anand, Abhijeet</creatorcontrib><title>The best route</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>[Miranda-Filho DB] and colleagues,2 in a randomised controlled trial of 120 patients with tetanus, allocated 58 patients to antitetanus globulin by the intrathecal and intramuscular route (treatment group), and 62 to antitetanus globulin by the intramuscular route (controls). Patients in the treatment group had greater clinical benefits than controls. Those treated by the intrathecal route had a better disease progression than those treated intramuscularly.</description><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Infusions, Intravenous</subject><subject>Injections, Intramuscular</subject><subject>Injections, Spinal</subject><subject>Tetanus</subject><subject>Tetanus - therapy</subject><subject>Tetanus Antitoxin - administration & dosage</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkEtLAzEUhYMotlb9B0pREF2M3kxzk8xKpPiCggsruAszyR2c0nZqMiP4700fKAji6m6-e87hY-yIwyUHLq-egQtIpBrIcxAXXKVSJ3yLdblQIkGhXrdZ9xvpsL0QJgAgJOAu63BEAK11lx2O36hfUGj6vm4b2mc7ZT4NdLC5PfZydzsePiSjp_vH4c0osQMpmqTkurCSO9LCOlJO8yyTBDJDR04gloA5al2gtgSKNKFMuU4B0gJzVZaDHjtb5y58_d7GejOrgqXpNJ9T3QYjFQCmKovg6S9wUrd-HreZNPZliJjySJ38RcVlwCFSEcI1ZH0dgqfSLHw1y_2n4WCWTs3KqVkKMyDMyqlZhh9vwttiRu7nayMxAtdrgKKxj4q8CbaiuSVXebKNcXX1T8UXgqOBxw</recordid><startdate>20041023</startdate><enddate>20041023</enddate><creator>Kashyap, Ajit Singh</creator><creator>Anand, Kuldip Parkash</creator><creator>Kashyap, Surekha</creator><creator>Anand, Abhijeet</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20041023</creationdate><title>The best route</title><author>Kashyap, Ajit Singh ; Anand, Kuldip Parkash ; Kashyap, Surekha ; Anand, Abhijeet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-f18bc61de84cde7d81996e0695ded455f05a588b58ce07e8e562182002b5a7ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Infusions, Intravenous</topic><topic>Injections, Intramuscular</topic><topic>Injections, Spinal</topic><topic>Tetanus</topic><topic>Tetanus - therapy</topic><topic>Tetanus Antitoxin - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kashyap, Ajit Singh</creatorcontrib><creatorcontrib>Anand, Kuldip Parkash</creatorcontrib><creatorcontrib>Kashyap, Surekha</creatorcontrib><creatorcontrib>Anand, Abhijeet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kashyap, Ajit Singh</au><au>Anand, Kuldip Parkash</au><au>Kashyap, Surekha</au><au>Anand, Abhijeet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The best route</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2004-10-23</date><risdate>2004</risdate><volume>364</volume><issue>9444</issue><spage>1487</spage><epage>1488</epage><pages>1487-1488</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>[Miranda-Filho DB] and colleagues,2 in a randomised controlled trial of 120 patients with tetanus, allocated 58 patients to antitetanus globulin by the intrathecal and intramuscular route (treatment group), and 62 to antitetanus globulin by the intramuscular route (controls). Patients in the treatment group had greater clinical benefits than controls. Those treated by the intrathecal route had a better disease progression than those treated intramuscularly.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15500888</pmid><doi>10.1016/S0140-6736(04)17268-1</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2004-10, Vol.364 (9444), p.1487-1488 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67005279 |
| source | MEDLINE; EBSCOhost Business Source Complete; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Female Humans Immunoglobulins Infusions, Intravenous Injections, Intramuscular Injections, Spinal Tetanus Tetanus - therapy Tetanus Antitoxin - administration & dosage |
| title | The best route |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A08%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20best%20route&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Kashyap,%20Ajit%20Singh&rft.date=2004-10-23&rft.volume=364&rft.issue=9444&rft.spage=1487&rft.epage=1488&rft.pages=1487-1488&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(04)17268-1&rft_dat=%3Cproquest_cross%3E726805981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199010552&rft_id=info:pmid/15500888&rft_els_id=S0140673604172681&rfr_iscdi=true |